Multiple Sclerosis and Neuroimmunological Disorders (Clinic)
Why choose us?

Each patient with Multiple Sclerosis experiences the disease in a special and unique way in relation to other patients facing the same medical problem. This uniqueness makes it imperative to develop an individualised diagnostic and therapeutic plan, according to the needs and personality of each patient. The Clinic of Multiple Sclerosis and Neuroimmunological Disorders of St. Luke's Hospital offers individualised counselling, combining modern diagnostic and therapeutic possibilities around Multiple Sclerosis and the entire range of autoimmune disorders of the nervous system.


For any information or to make an appointment, you can contact the Secretariat of the Clinic
+30 2310 390 766 | +30 2310 380 000

At St. Luke's Hospital, there is a Clinic for Multiple Sclerosis and Neuroimmunological Disorders. The Clinic is addressed to all patients who suffer from the disease or who show symptoms of other neuroimmunological disorders. The Clinic plays a key role in the early diagnosis of Multiple Sclerosis and the referral of the patient for further examination. 



What is multiple sclerosis (MS)

Multiple Sclerosis is a chronic, autoimmune, inflammatory disease of the central nervous system, i.e. the brain and spinal cord. This disease is characterized in its early stages by the production by the body itself of an inflammatory reaction, in which the main elements of our immune system participate. This reaction has as its ultimate goal the destruction of the myelin sheath. Myelin damage leads to nerve dysfunction and the appearance of the first manifestations of the disease. 



Services offered

The Clinic, in collaboration with other departments, such as Haematology, Orthopaedics, Ophthalmology and Neurosurgery, offers patients a holistic treatment of the disease and other neuroimmunological disorders. The holistic and individualised treatment of the disease facilitates the work of the attending physician and contributes to the improvement of the patient's quality of life. Some of the services offered are:



Monoclonal antibodies

New therapeutic horizons in Multiple Sclerosis

Monoclonal antibodies are specific antibodies, which are prepared in the laboratory and are aimed at connecting or destroying a predetermined target within the human body. The officially approved monoclonal antibodies to Multiple Sclerosis are the following:



Based on the relevant studies, natalizumab reduced the risk of developing disability in Multiple Sclerosis by 42% in the first two years and the number of clinical relapses by 68% in the first year of treatment. At the same time, patients who received this treatment experienced an 83% reduction in the number of new lesions in the first two years on the brain MRI.



Based on relevant studies, alemtuzumab reduced the risk of progression of disability in MULTIPLE SCLEROSIS by 42% and the number of clinical relapses by 49% during the first 2 years of its use.


Other monoclonal antibodies for which there are studies in MULTIPLE SCLEROSIS



Treatment plan of Multiple Sclerosis

Treatment for Multiple Sclerosis has unfortunately not been discovered yet. The therapeutic strategy involves the reduction of relapses of the disease with the use of appropriate monoclonal antibodies and targeted symptomatic therapy to improve neurological discomfort. 


The doctors of the department:

No Doctors found.
The doctors of the department:

Useful tips for your hospitalisation

Communication

Fill in the form below to contact the Clinic. Your request will be registered immediately. One of the representatives of the Clinic will contact you to serve you. 

Your request has been registered. One of the representatives of the Clinic will contact you as soon as possible.
Thanks
"AGIOS LOUKAS" Clinic
Oops! Something went wrong while submitting the form.